Erratum to: The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells (British Journal of Cancer, (1996), 74, 5, (688-697), 10.1038/bjc.1996.423);The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 688-697

  Berg, K ^a   Anholt, H ^a   Bech, O ^a   Moan, J ^a  

^a Molecular Medicine Group   (Norway)

Author keywords

Aminolaevulinic acid; Ferrochelatase; Iron chelator; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; CHELATING AGENT; DEFEROXAMINE; EDETIC ACID; PROTOPORPHYRIN;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL STRAIN V 79; CONTROLLED STUDY; DRUG POTENTIATION; IRON CHELATION; LIGHT EXPOSURE; LUNG FIBROBLAST; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0029763913     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1997.320     Document Type: Erratum

References (40)

1. AULER H AND BANZER G. (1943). Untersuchungen uber die rolle der porphyrine bei geschwulstkranken menschen und tieren. Z Krebsforschungen, 53, 65 68.
2. BERG K, HOVIG E AND MOAN J. (1988). Sister chromatid exchanges induced by photodynamic treatment of cells in the presence of Photofrin II, aluminum phthalocyanine tetrasulfonate and tetra(3-hydroxyphenyl)porphyrin. In Light in Biology and Medicine. Douglas J, Dall'Aqua F, Moan J. (eds) pp. 95-103. Plenum Press: New York.
3. BFRG K, MADSLIEN K, BOMMER JC, OFTEBRO R, WINKELMAN JW AND MOAN J. (1991). Light induced relocalization of sulfonated meso-tetraphenylporphines in NHIK 3025 cells and effects of dose fractionation. Photochem. Photobiol., 53, 203-210.
4. BLATT J. (1994). Deferoxamine in children with recurrent neuroblastoma. Anticancer Res., 14, 2109-2112.
5. BRADY AM AND LOCK EA. (1992). Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals. Arch. Toxicol., 66, 175-181.
6. DAILEY HA AND SMITH A. (1984). Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem. J., 223, 441-445.
7. EL-SHARABASY MM, EL-WASEEF AM, HAFEZ MM AND SALIM SA. (1992). Porphyrin metabolism in some malignant diseases. Br. J. Cancer, 65, 409 412.
8. FERREIRA GC. (1994). Mammalian ferrochelatase. Overexpression in Escherichia coli as a soluble protein, purification and characterization. J. Biol. Chem., 269, 4396-4400.
9. GAULLIER JM, GEZE M, SANTUS R, SA E, MELO T, MAZIERE JC, BAZIN M, MORLIERE P AND DUBERTRET L. (1995). Subcellular localization of and photosensitization by protoporphyrin IX in human keratinocytes and fibroblasts cultivated with 5-aminole-vulinic acid. Photochem. Photobiol., 62, 114-122.
10. GRANICK S, SINCLAIR P, SASSA S AND GRIENINGER G. (1975). Effects by heme, insulin, and serum albumin on heme and protein synthesis in chick embryo liver cells cultured in a chemically defined medium, and a spectrofluorometric assay for porphyrin composition. J. Biol. Chem., 250, 9215 9225.
11. HANANIA J AND MALIK Z. (1992). The effect of EDTA and serum on endogenous porphyrin accumulation and photodynamic sensitization of human K562 leukemic cells. Cancer Lett., 65, 127-131.
12. HENDERSON B AND DOUGHERTY TJ. (1992). How does photodynamic therapy work? Photochem. Photobiol., 55, 145-157.
13. HEYERDAHL H, WARLOE T, PENG Q, SVANBERG K, MOAN J, STEEN H, SVAASAND L AND GIERCKSKY K. (1993). Dosimetry and light distribution systems for photodynamic therapy at the Norwegian Radium Hospital. In Photodynamic Therapy of Cancer, Jori G, Moan J, Star W. (eds) pp. 27-36. SPIE: Bellingham.
14. IINUMA S, FARSHI SS, ORTEL B AND HASAN T. (1994). A mechanistic study of cellular photodestruction with 5-aminolae-vulinic acid-induced porphyrin. Br. J. Cancer, 70, 21-28.
15. JACOBS A. (1977). Low molecular weight intracellular iron transport compounds (review). Blood, 50, 433 439.
16. KEBERLE H. (1964). The biochemistry of desferrioxamine and its relation to iron metabolism. Anns. N. Y. Acad. Sci., 19, 758 768.
17. KELLY JE AND SNELL ME. (1976). Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder. J. Urol., 115, 150-157.
18. KENNEDY JC, POTTIER RH AND PROSS DC. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol., 6, 143-148.
19. KENNEDY JC AND POTTIER RH. (1992). Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy (review). J. Photochem. Photobiol. B Biol., 14, 275-292.
20. KIMMETT SM, WHITNEY RA AND MARKS GS. (1992). Evidence for the stereoselective inhibition of chick embryo hepatic ferrochelatase by N-alkylated porphyrins. II. Mol. Pharmacol., 42, 307-310.
21. LIPSON RL, BALDES EJ AND GRAY M. (1967). Hematoporphyrin derivative for detection and management of cancer. Cancer, 20, 2255-2257.
22. LOWRY OH, ROSEFROUGH NJ, FARR AL AND RANDALL RJ. (1951). Protein measurement with the Folin phenol reagent. J Biol. Chem., 193, 265-275.
23. MALIK Z AND LUGACI H. (1987). Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br. J. Cancer, 56, 589-595.
24. MOAN J AND BERG K. (1992). Photochemotherapy of cancer: experimental research (review). Photochem. Photobiol., 55, 931-948.
25. NOGUCHI P, WALLACE R, JOHNSON J, EARLEY EM, O'BRIEN S, FERRONE S, PELLEGRINO MA, MILSTEIN J, NEEDY C, BROWNE W AND PETRICCIANI J. (1979). Characterization of the WIDR: a human colon carcinoma cell line. In Vitro, 15, 401-408.
26. ORENSTEIN A, KOSTENICH G, TSUR H, ROITMAN L, EHRENBERG B AND MALIK Z. (1994). Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA. In Photodynamic Therapy of Cancer II. Brault D, Jori G, Moan J, Ehrenberg B. (eds) pp. 100-105. SPIE: Bellingham.
27. ORTEL B, TANEW A AND HONIGSMANN H. (1993). Lethal photosensitization by endogenous porphyrins of PAM cells modification by desferrioxamine. J. Photochem. Photobiol. B Biol., 17, 273-278.
28. ORTIZ DE MONTELLANO PR, BEILAN HS AND KUNZE KL. (1981). N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin. J. Biol. Chem., 256, 6708-6713.
29. PENG Q, MOAN J, IANI V AND NESLAND JM. (1996). Effect of desferrioxamine on production of ALA-induced protoporphyrin IX in normal mouse skin. In Photochemotherapy:Photodynamic Therapy and Other Modalities. Eherenberg B, Jori G, Moan J. (eds) pp. 51-57. SPIE:Bellingham.
30. POLICARD A. (1924). Etudes sur les aspects offert par des tumeurs experimentales examinees a la lumiere de Wood. C R Soc. Biol., 91, 1423-1424.
31. POPE AJ, MACROBERT AJ, PHILLIPS D AND BOWN SG. (1991). The detection of phthalocyanine fluorescence in normal rat bladder wall using sensitive digital imaging microscopy. B. J. Cancer, 64, 875-879.
32. REBEIZ N, REBEIZ CC, ARKINS S, KELLEY KW AND REBEIZ CA. (1992). Photodestruction of tumor cells by induction of endogenous accumulation of protoporphyrin IX: enhancement by 1,10-phenanthroline. Photochem. Photobiol., 55, 431-435.
33. RICHARDSON D, PONKA P AND BAKER E. (1994). The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res., 54, 685-689.
34. RITTENHOUSE-DIAKUN K, VAN LEENGOED H, MORGAN J, HRYHORENKO E, PASZKIEWICZ G, WHITAKER JE AND OSEROFF AR. (1995). The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem. Photobiol., 61, 523-528.
35. ROSSI E, ATTWOOD PV, GARCIA-WEBB P AND COSTIN KA. (1990). Inhibition of human lymphocyte ferrochelatase activity by hemin. Biochim. Biophys. Acta, 1038, 375-381.
36. SASSA S AND BERNSTEIN SE. (1977). Levels of delta-aminolevulinate dehydratase, uroporphyrinogen-I synthase, and protoporphyrin IX in erythrocytes from anemic mutant mice. Proc. Natl Acad. Sci. USA, 74, 1181-1184.
37. SCHOENFELD N, EPSTEIN O, LAHAV M, MAMET R, SHAKLAI M AND ATSMON A. (1988). The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett., 43, 43-48.
38. SCHOENFELD N, MAMET R, NORDENBERG Y, SHAFRAN M, BABUSHKIN T AND MALIK Z. (1994). Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int. J. Cancer, 56, 106-112.
39. TAKETANI S AND TOKUNAGA R. (1982). Purification and substrate specificity of bovine liver-ferrochelatase. Eur. J. Biochem., 127, 443-447.
40. VAN HILLEGERSBERT R, VAN DEN BERT JW, KORT WJ, TERPSTRA OT AND WILSON JH. (1992). Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology, 103, 647-651.